Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Developing A Policy For Second-Generation Antipsychotic Drugs
Health Affairs, 09/22/09
Rosenheck RA et al. – Second–generation antipsychotics (SGAs) have replaced older drugs in the treatment of schizophrenia; their costs in the United States have reached $13 billion a year. Recent research, however, shows that their net risk/benefit profiles are no better than some older, cheaper drugs. Stepped therapy, allowing exceptions with prior authorization and giving preference to generic drugs with low risk of both neurologic and metabolic side effects, could increase the cost–effectiveness and safety of antipsychotic drugs.
Related Articles
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Neuropsychiatric Disease and Treatment, 10/02/09
Relevance Score: 68%
Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
Biological Psychiatry, 11/05/09
Relevance Score: 66%
Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients
European Psychiatry, 11/06/09
Relevance Score: 65%
Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09
Relevance Score: 65%
Junior doctors' knowledge and practice of electrocardiographic monitoring for high-risk patients receiving antipsychotic medications
Psychiatric Bulletin, 10/05/09
Relevance Score: 65%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services
Social Psychiatry and Psychiatric Epidemiology, 11/25/09
Antipsychotic Prescribing Practices Following Withdrawal of Concomitant Carbamazepine
Journal of Psychiatric Practice, 11/24/09
Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness
Schizophrenia Bulletin, 11/24/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services
Social Psychiatry and Psychiatric Epidemiology, 11/25/09
Altered Prefrontal and Hippocampal Function During Verbal Encoding and Recognition in People With Prodromal Symptoms of Psychosis
Schizophrenia Bulletin, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


